Business Description
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.88 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 34.24 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 325.4 | |||||
3-Year EBITDA Growth Rate | -31.1 | |||||
3-Year EPS without NRI Growth Rate | -21 | |||||
3-Year FCF Growth Rate | -49.1 | |||||
3-Year Book Growth Rate | 77.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 12.97 | |||||
9-Day RSI | 21.84 | |||||
14-Day RSI | 29.18 | |||||
6-1 Month Momentum % | -6.04 | |||||
12-1 Month Momentum % | 17.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.27 | |||||
Quick Ratio | 5.27 | |||||
Cash Ratio | 4.2 | |||||
Days Sales Outstanding | 49.05 | |||||
Days Payable | 207.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -30.8 | |||||
Shareholder Yield % | -8 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -20.95 | |||||
Operating Margin % | -1643.39 | |||||
Net Margin % | -1632.84 | |||||
FCF Margin % | -1526.17 | |||||
ROE % | -99.39 | |||||
ROA % | -91.98 | |||||
ROIC % | -233.41 | |||||
ROC (Joel Greenblatt) % | -263.29 | |||||
ROCE % | -99.45 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 86.32 | |||||
PB Ratio | 7.16 | |||||
Price-to-Tangible-Book | 5.9 | |||||
EV-to-EBIT | -5.54 | |||||
EV-to-EBITDA | -5.89 | |||||
EV-to-Revenue | 90.61 | |||||
EV-to-FCF | -6.64 | |||||
Price-to-Net-Current-Asset-Value | 11.8 | |||||
Price-to-Net-Cash | 11.8 | |||||
Earnings Yield (Greenblatt) % | -18.03 | |||||
FCF Yield % | -14.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bioextrax AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.107 | ||
EPS (TTM) (€) | -0.056 | ||
Beta | -1.44 | ||
Volatility % | 53.85 | ||
14-Day RSI | 29.18 | ||
14-Day ATR (€) | 0.012031 | ||
20-Day SMA (€) | 0.2736 | ||
12-1 Month Momentum % | 17.75 | ||
52-Week Range (€) | 0.140675 - 0.3505 | ||
Shares Outstanding (Mil) | 40.03 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bioextrax AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bioextrax AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Bioextrax AB Frequently Asked Questions
What is Bioextrax AB(FRA:85X0)'s stock price today?
When is next earnings date of Bioextrax AB(FRA:85X0)?
Does Bioextrax AB(FRA:85X0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |